RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
RT @rendocrinology: As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (…
As a pediatric endocrinologist, I can say with certainty: insulin saves lives. As of 2018, ~7.4 million people use it (https://t.co/hFjwSEqO73). And, as the article stated, insulin is NECESSARY for those with type 1 diabetes. As in, they die without it. So
@UnhitchingHour @What46HasDone I found a source saying 7.4 million. https://t.co/mAHC15CHUQ. Also diabetes is rising so that number will be close to 8mil by 2030.
@darylhawkRN @Chris_j_baker @gbosslet @SenToddYoung @SenatorBraun Lots of significant changes have been made to formulation. As an RN, educate yourself please: https://t.co/VW7ZIJgs3P
@AkonOfBoston @gbosslet @SenToddYoung @SenatorBraun That's one possible explaination, but since there are 3 different insulin manufacturers in the US, that would require (I assume illegal) collusion on pricing. I found this illuminating: https://t.co/VW7Z
RT @Stylopidae: Tweeting this entire paper would take forever, and I have a job to apply to. However, I would reccomend that anyone intere…
@JangoKitty @LourinHubbard Fine. A 10ml vial of insulin costs $2.28 to manufacture. (c: https://t.co/Xo5Q3xV8Zd). The current cost of that vial on the open market in $174. (c: https://t.co/3rhQel7uLl)
@SpinningBy There hasn't been a Senate vote yet. Something has to be done about insulin price-gouging. It affects millions: "Approximately 7.4 million Americans with diabetes use one or more formulations of insulin." https://t.co/uE5LbQFegw.
@jurijkovalenok1 @POTUS It's probably not so much "pay" but rather cut down on all the markups that medicine companies tack on that have been sharply increasing (Source: https://t.co/PHIg8HUtuv) https://t.co/CLcn920qdL
"As the price of insulin continues to rise, individuals with diabetes are often forced to choose between purchasing their medications or paying for other necessities, exposing them to serious short- and long-term health consequences (4–9)." https://t.co/Ry
@sergeant_porn @BaronGalactic @David_Leavitt You truly have no idea what you're talking about. The price of insulin has nothing to do with supply and demand. Read this and get back to me. https://t.co/GryiihjCKR
RT @HLFrisbie: Y llego la industria farmacéutica, se apropió de su manufactura y hoy el 25%-30% de los pacientes no pueden cubrir el excesi…
RT @HLFrisbie: Y llego la industria farmacéutica, se apropió de su manufactura y hoy el 25%-30% de los pacientes no pueden cubrir el excesi…
RT @HLFrisbie: Y llego la industria farmacéutica, se apropió de su manufactura y hoy el 25%-30% de los pacientes no pueden cubrir el excesi…
RT @HLFrisbie: Y llego la industria farmacéutica, se apropió de su manufactura y hoy el 25%-30% de los pacientes no pueden cubrir el excesi…
RT @HLFrisbie: Y llego la industria farmacéutica, se apropió de su manufactura y hoy el 25%-30% de los pacientes no pueden cubrir el excesi…
RT @HLFrisbie: Y llego la industria farmacéutica, se apropió de su manufactura y hoy el 25%-30% de los pacientes no pueden cubrir el excesi…
Y llego la industria farmacéutica, se apropió de su manufactura y hoy el 25%-30% de los pacientes no pueden cubrir el excesivo costo de la Insulina https://t.co/wRk2BJilRy https://t.co/0U5bYOrhjO
@DusetzinaS These authors. https://t.co/F8sjkN6Vom
@TiffIsWayward @LifeSciVC There is no patent exclusivity preventing others from manufacturing insulin, hence AOC’s comment is inane. The regulatory burden to make a biosimilar is onerous to your point. Helpful article on issues: https://t.co/lg
@myfanwy123 @Rolf_Endres @AOC @JeremyCliffe Inflection point where in 2010? https://t.co/X3jjtUaT8d Citizen’s United has issues, but it’s really not at all part of the insulin price issues, that was going on for at least a decade already by that point.
@jodongo @sthotwhelz @BernieSanders But don't take my word for it: https://t.co/YAYuLoSUq2
@lightwarrior_RN @RealPattyWap @Kidfears99 He got something done, but he was looking out for pharma more than people. https://t.co/EoMw15zwX8
@DanaTims Typically your one-liners leave me speechless😀. But like a broken clock is right 2x/day, George isn't wrong here. From the ADA white paper- https://t.co/H60cGVmVYc BTW, what does *typical* mean? 😉 https://t.co/ewKVCobdwY
RT @DBelardoMD: @CupcakesForYou7 @DC_CaseyD It seems the pricing is due to PBMs, rather than pharma itself. This is an excellent paper on i…
@CupcakesForYou7 @DC_CaseyD It seems the pricing is due to PBMs, rather than pharma itself. This is an excellent paper on it. https://t.co/nErmCAX4Bt https://t.co/1t6CGLqgX0
Based on numbers from 2018, injectable insulin dependent Americans spend $182.5 million daily on their insulin needs. #insulin4all https://t.co/ebsRJY7RLg
@misskaminsk @Kidfears99 @AmDiabetesAssn https://t.co/NUth9C6KoJ In our white paper... We recommend providers “prescribe the lowest-priced insulin required to effectively and safely achieve treatment goals,” which may include using human insulin in selecte
@ewarren The US needs to establish a non profit pharma manufacturing facility. This would strengthen the ACA by reducing costs. Possible use of the DPA? We can order tanks, airplanes and rockets, etc. https://t.co/MgPBwagfdN.
Background & extension information to understand the scope of the #insulin #diabetes price problem as only 3 companies in the USA make insulin & cost gouge diabetic people for their life critical medication https://t.co/wII8VuExVx.
@SenSanders This says that human insulin in the US can be had for as little as $25. https://t.co/XUor6I7ocT
@tyronemund @samanthadjb I’m referring to Humalog. https://t.co/gJ5z7j3Khx
@alphabravo_15 @AmberMaureen2 @AKF052 @SenatorDole @realDonaldTrump The average price of insulin nearly tripled between 2002 and 2013 https://t.co/H2Nlidnsvb What “best coverage” did you get from Trump, who has made no changes to healthcare and/or Rx drug
@tbr90 Insulin makers in the US 😑 https://t.co/dDaqX1XQ9e.
@AnnAnne700 I could explain why you're wrong or you could read this journal article, which would you prefer? https://t.co/wf9pbiOohf
RT @ianmc46_ian: @davidsirota @NoFascistLies This is why big pharma want not only unfettered access to UK market - they want to control pri…
DIABETES List price of Insulin "The average list price of #insulin has skyrocketed in recent years, nearly tripling between 2002 and 2013. The reasons for this increase are not entirely clear..." https://t.co/8bDTohyldq
RT @ianmc46_ian: @davidsirota @NoFascistLies This is why big pharma want not only unfettered access to UK market - they want to control pri…
@davidsirota @NoFascistLies This is why big pharma want not only unfettered access to UK market - they want to control pricing as well. Know anyone using insulin? Many American people needing to use it can not afford to buy it. Do we want this here? Wake u
https://t.co/NFOHy97hum Insulin access is key to help those with #diabetes manage it. #insulin #health #NCDs
@Robot_Bastard @SyndieCass @mungowitz @JonahDispatch This isn't even close to correct. This is what I'm talking about. Libertarianism is a fantasy world constructed for children. https://t.co/NTrqhtNv0b
@carterforva @MsShade I just found out that because of deep discounts provided to healthcare systems the list price of insulin is growing way faster than the net price. only the uninsured pay the crazy high list price. https://t.co/y4CADWCK7g https://t.co
@SteveScalise I call bullshit. “As the price of insulin continues to rise, individuals with diabetes are often forced to choose between purchasing their medications or paying for other necessities, exposing them to serious short- and long-term health conse
@nataliesurely @newrepublic I read this last week https://t.co/y4CADWCK7g one key take away is the list price of insulin has inflated way more than the net price. insurance company’s get tremendous discounts on insulin - if you are not on insurance or in o
RT @lemmy_caution2: @eponawest this was interesting on the cost issues https://t.co/y4CADWCK7g the pharmaceutical companies definitely ar…
@eponawest this was interesting on the cost issues https://t.co/y4CADWCK7g the pharmaceutical companies definitely are jacking up the cost in a coordinated and non competitive manner there are a lot of discounts for insulin that are not available for th
@ea_neil @billykilroy @mommagrizzly74 This isn't Trumps fault. We are as world seeing huge increases in people using insulin. it's been going on before Trump. https://t.co/gvI2ocK0Xy on the rapidly increasing average list prices of insulin over the past
@sparflorida @rhettod @pcmanet is this article better> https://t.co/JNEeaKyyHF
@TonyMor70714598 @EricDJuly @22_over7 @DemkinAlexander @HereWeAre1 @RodentMessiah how about you use a real source like this one that is a diabetes site that states insulin costs between $25 - $300 depending on human or artificial. which still isnt $350/ v
@MikeBloomberg @SamLiccardo Q: How many bottles of insulin does one million dollars buy? A: About 5,000 vials. Q: How many millions did you spend on ads again? https://t.co/b5YMW1iBpj
@trishgreenhalgh @mirabarhillel @ProfBrianCox
Price is determined by supply and demand in a free market. Regulation muddies the waters. https://t.co/xJwFETfYrb
@LuarLuta Si, mira, aquí tienes la del CDC : https://t.co/ROJ62PMpc2 Y sobre la insulina aquí tienes unas tablas con colorines para que hasta tu puedas ver lo que hace el sector privado cuando se le deja libre https://t.co/mqTy5LX3sd
@HumanProgress @AEI @Heritage @JonahDispatch @michaelbd @BrianLehrer @GanucheauAdam @RubinReport @EconTalker @nytdavidbrooks The price of chicken isn't a life-or-death matter. The price of insulin *is*. https://t.co/QgmMInVObP
@Datanerdkim @TheDemocrats @ewarren Not as simple as you might think. https://t.co/C3H6fwCkai
@AsianFinDomme @AOC Read this https://t.co/l3aBSKAVbf
Your supplement for New Amsterdam S2E1 https://t.co/3SYDLoNuPz
RT PPA_USA: RT Docbasia: FennerMichelle mass_marion WillGuzzardi PPA_USA Free2CareHC physvrxshortage AAPSonline PedsMamaDoc kksheld PatientsandDocs somedocs IP4PI amychomd https://t.co/8rbverjZOS
@abu_hobbit @roh_min_hon @smallweed זה כשל שוק ענק, עם ריח של קרטל וסחיטה. חברות ההפצה סוחטות את היצרנים, ואלה מעלים את המחירים בתיאום כמו שיחות סלולריות לפני כחלון. וגם כשאין פטנטים, סף הכניסה לשוק עצום, כי יצרני תרופות ביולוגיות חייבים להוכיח את בטיחותם
RT @RRalstonAgile: Currently, there are only three insulin manufacturers serving the U.S. market: Eli Lilly, Novo Nordisk, and Sanofi. Almo…
RT @RRalstonAgile: Currently, there are only three insulin manufacturers serving the U.S. market: Eli Lilly, Novo Nordisk, and Sanofi. Almo…
RT @RRalstonAgile: Currently, there are only three insulin manufacturers serving the U.S. market: Eli Lilly, Novo Nordisk, and Sanofi. Almo…
Currently, there are only three insulin manufacturers serving the U.S. market: Eli Lilly, Novo Nordisk, and Sanofi. Almost 100 years ago, the discovery of insulin, derived from animal sources, literally began to save human lives. https://t.co/7uhAMxPvIQ
@LeahHoustonMD This is an excellent overview of the problem. A quite the problem it is. https://t.co/7Fy5Mw0CeU
@HalMarshall2309 @TamiDaBushPilot @Public_Citizen No. There are averages for all people, all people with a certain ailment, and average costs paid for specific meds. All are better indicators than list price. Pricing is extremely complicated, but private i
@chrieke Insulin analogs have been around since the 90s, but use has really only increased over human insulin (“cheap Walmart insulin”) in the past decade. In reality, doctors over-prescribe analog insulin for patients who could use the cheaper human insul
Because you or your doctor are lazy, shouldn’t mean taxpayers should fit the bill. Insulin Access and Affordability Working Group: Conclusions and Recommendations | Diabetes Care https://t.co/JTy4hz7Lmv
@WholiCrypto @jeffchristmas @AOC @ODonnell4NH Absolutely is. You cannot be lazy, and actually have to educate yourself on your condition. But isn’t that what all of us do when we have a chronic condition? https://t.co/JTy4hz7Lmv
RT @Stylopidae: When anti-GMO activists talk about industry valuing profits over the health of people, insulin is the textbook example. Giv…
RT @Stylopidae: When anti-GMO activists talk about industry valuing profits over the health of people, insulin is the textbook example. Giv…
@goodtran1 @jakefm As this exhaustive report demonstrates the fault does not lie solely with the drug maker as many have assumed https://t.co/tKhB2PYcJO
RT @eeberquist: @nk_prof @MangroveStar @bdk1521 I don't understand all the nuances, but from what I've read it's not simply the manufacture…
RT @SOSReport: @stupidythings @NHSMillion Horrifying. Interested in how that $1,000 breaks down. So according to this https://t.co/fogs0t1D…
@stupidythings @NHSMillion Horrifying. Interested in how that $1,000 breaks down. So according to this https://t.co/fogs0t1Dls a single 'vial' can costs between $25-$300. Presumably you need 1 vial a day? So $750-$9,000 a month? Before or after insurance?
Insulin Access and Affordability Working Group: Conclusions and Recommendations | Diabetes Care @AOC https://t.co/e1lNTEfEHI
@Kidfears99 @WSJopinion @WSJ Thought I'd cropped off source but it's not on graph. Thanks Laura! https://t.co/MEORlmAwxc https://t.co/EPdrqQG7EN
RT @michael_ag__: Some fun charts I found plus the markup source I used and good links to learn more https://t.co/Cd5cHGy94u https://t.c…